Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"

Intensive Care Med. 2003 Jul;29(7):1196. doi: 10.1007/s00134-003-1842-8. Epub 2003 Jun 13.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candidiasis / complications
  • Candidiasis / prevention & control*
  • Critical Illness*
  • Humans
  • Switzerland

Substances

  • Antifungal Agents